Posted on Leave a comment

Chondrosarcoma Market is Projected to Witness Significant Growth by 2036 Owing to the Emergence of Targeted Therapies and Growing Focus on IDH-mutant Disease | DelveInsight

The market dynamics for Chondrosarcoma are witnessing steady growth driven by increasing detection rates, advances in imaging and diagnostic sensitivity, growing understanding of the molecular drivers of the disease, and the significant unmet need for effective systemic therapies. (Albany, New York)- 5th Sep 2026, The market dynamics for Chondrosarcoma are witnessing steady growth driven by […]

Posted on Leave a comment

Sarcoidosis Market Expected to Gain Momentum Through 2036, According to DelveInsight

(Albany, New York)- 5th Sep 2026, DelveInsight’s Sarcoidosis Market Insights, Epidemiology, and Market Forecast 2036 report delivers an in-depth understanding of Sarcoidosis, historical and forecasted epidemiology, as well as Sarcoidosis market trends across the United States, EU4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan. The Sarcoidosis Market Report provides real-world prescription pattern analysis, […]

Posted on Leave a comment

Diabetes Clinical Trial Drug Development Pipeline Expands with Contributions from 200+ Key Companies | DelveInsight

The Diabetes clinical trial analysis report delivers important insights into ongoing research on 200+ pipeline Diabetes drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, New York, USA) September 05, 2026– DelveInsight’s “Diabetes Pipeline Insight 2026” report provides comprehensive insights about 200+ companies and 200+ pipeline drugs in the Diabetes pipeline landscape. It covers the […]

Posted on Leave a comment

COVID-19 Clinical Trial Pipeline Appears Robust With 180+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

The COVID-19 clinical trial analysis report delivers important insights into ongoing research on 180+ pipeline COVID-19 drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, New York, USA) September 05, 2026- DelveInsight’s “COVID-19 Pipeline Insight 2026” report provides comprehensive insights about 180+ companies and 200+ pipeline drugs in the COVID-19 pipeline landscape. It covers the […]

Posted on Leave a comment

Chronic and Acute Pain Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 180+ Leading Players Wheeling the Therapeutics Landscape

The Chronic and Acute Pain clinical trial analysis report delivers important insights into ongoing research of 180+ pipeline Chronic and Acute Pain drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, New York, USA) September 05, 2026- DelveInsight’s, “Chronic and Acute Pain Pipeline Insight, 2026” report provides comprehensive insights about 180+ companies and 200+ pipeline […]

Posted on Leave a comment

Liver Cirrhosis Pipeline Gains Momentum: 30+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

Gurugram, India (September 02, 2026): DelveInsight’s “Liver Cirrhosis Pipeline Insight 2026” report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in the Liver Cirrhosis Pipeline landscape. It covers the Liver Cirrhosis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Liver Cirrhosis therapeutics assessment by product type, stage, route […]

Posted on Leave a comment

Independent Research Finds 77% Of Commercial Sunscreens Fail Efficacy Or Contain Hidden Chemical UV Filters, Sky & Sol Ranked #1 Zinc Oxide Sunscreen For 2026.

Best Zinc Oxide Sunscreen 2026 research review banner featuring a white SPF 50 mineral sunscreen tube on a stone platform with a cream swatch. Independent research reveals that 77% of commercial sunscreens fail efficacy standards or contain hidden chemical UV filters. To combat “sunscreen doping,” Crestmore Research evaluated leading brands for safety and purity. Sky […]

Posted on Leave a comment

Creative Diagnostics Launches Untargeted Metabolomics Services to Accelerate Biomarker Discovery and Metabolic Research

Creative Diagnostics announces Untargeted Metabolomics Services to support research applications. New York, NY, United States – AUGUST 31, 2026 – Creative Diagnostics, a reagent supplier and developer focused on biologics quality control, is pleased to announce its comprehensive Untargeted Metabolomics Services, to provide researchers with unbiased, high-resolution metabolic profiling for a wide range of biological […]

Posted on Leave a comment

CD Bioparticles Launches Comprehensive Exosomes for Cosmetics Solutions to Advance Skincare Innovation

CD Bioparticles launches specialized Exosomes for Cosmetics product portfolio. New York, NY, United States – AUGUST 31, 2026 – CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, has announced the expansion of its offering with the launch of its specialized Exosomes for Cosmetics product portfolio. This product line provides […]

Posted on Leave a comment

Ibogaine by David Dardashti Celebrates Ten Years of Pioneering Kratom Addiction Treatment

Amidst recent 7-OH legislation, the clinic remains the only facility offering a direct-to-ibogaine protocol for kratom dependency, releasing a powerful 10-year updated video testimonial to mark the milestone. PLAYA DEL CARMEN, MEXICO – August 29, 2026 – Ibogaine by David Dardashti is proud to announce its ten-year anniversary of successfully treating kratom addiction. In a […]